Everything your hair needs to grow stronger and healthier, all in one formula.
Because hair loss rarely has one cause, Flourish Hair Growth Serum opens blood flow to dormant hair follicles, regulates the growth cycle, controls for a healthy scalp environment, and maximizes absorption of active ingredients — all at once. You have enough serums to remember; try our clinician-prescribed six-active combo, compounded for women whose hair loss demands more than a single-ingredient answer. For hair that thrives.
Size
100ml (30-day supply)WHAT TO EXPECT
Multi-pathway treatment results in flourishing hair over a bit of time. The actives in Flourish work on different biological timescales — some effects emerge in weeks; other structural improvements take months.
WEEKS 4–8
Ketoconazole starts to calm scalp inflammation, block the hormone signal that shrinks hair follicles, and primes your scalp to absorb minoxidil more effectively. You’ll notice less shedding before the new growth appears.
MONTHS 3–4
At this stage, the follicles that have been quietly reactivating start to show themselves. Fine, shorter hairs at the hairline and part are the first signs of new growth. Latanoprost, the ingredient that regulates the follicle growth cycle, builds hair density. Minoxidil is waking dormant follicles back up.
MONTHS 6–9
By this point, the results are both visible and measurable. More density, thicker strands, more active follicles across the scalp. Consistent use pays off as long-term data shows dutasteride increased hair thickness in over 83% of women with pattern hair loss.
Consistent daily use is the variable most within a patient’s control. Stopping treatment typically results in renewed progression of hair loss within 6–12 months. This is a long-term protocol — your HerTeleMeds clinician will guide your ongoing management. For FFA patients: frontal fibrosing alopecia (FFA) is the most common type of scarring alopecia, characterized by symmetric, progressive recession on the frontotemporal hairline. It most commonly affects postmenopausal women and unfortunately there is no cure. For patients with FFA, the goal of treatment is stabilization — slowing progression — rather than reversal. Flourish provides the 5-alpha reductase inhibition that international FFA experts identify as preferred systemic therapy, alongside the prostaglandin analog mechanism with emerging FFA evidence.
ABOUT THE TREATMENT
Because complex hair loss requires a multi-angled approach. Addressing one pathway while the others continue operating produces incomplete results. Flourish was formulated to address six pathways at once, giving your hair another chance.
Minoxidil 5% extends the growth phase by increasing scalp blood flow and oxygen delivery to follicles, transitioning once-dormant follicles into active growth. At 5%, it delivers a stronger signal than standard OTC formulations and is the only FDA-approved topical for female pattern hair loss.
Dutasteride 0.1% — DHT is the hormone that shrinks hair follicles over time, and it also triggers inflammation at the scalp. Dutasteride blocks DHT more completely than other treatments, targeting both issues head on.
Finasteride 0.1% adds a second layer of DHT blocking, targeting a pathway dutasteride doesn’t fully cover on its own. Together, the two ingredients shut down DHT production more completely than either one alone.
Latanoprost 0.005% extends the active growth phase of the hair cycle.
Tretinoin 0.01% does two jobs: it helps every other ingredient absorb more effectively, and it activates minoxidil at the follicle level. Studies show that nearly half of people who don’t respond to minoxidil alone start responding once tretinoin is added. It also supports healthy scalp cell turnover, keeping the environment receptive to treatment.
Ketoconazole 2% is an antifungal that also works against DHT. It clears the scalp of yeast that disrupts the follicle environment, reduces DHT-driven inflammation, and blocks androgen activity directly at the receptor. Research shows topical ketoconazole at this concentration produces hair-stimulating effects comparable to minoxidil in women with pattern hair loss.
HOW TO USE
STEP 01
Apply 0.5–1 dropperful directly to the scalp — not to the hair — focusing on areas of active thinning or recession. Part hair in sections to ensure serum contacts scalp directly. Nighttime application is essential: tretinoin is photosensitive, and the formula needs absorption time without UV exposure or rinsing.
STEP 02
Use clean fingertips to massage the serum across all target areas for 1–2 minutes. This supports minoxidil’s vasodilatory absorption and ensures even distribution of all six actives. Wash hands immediately and thoroughly after every application.
STEP 03
Allow the serum to dry fully before contact with pillows. Most patients apply 30–45 minutes before lying down. Do not wash hair for at least 4 hours after application.
STEP 04
This is the most important instruction. Each of the six actives depends on consistent, uninterrupted daily exposure at the scalp level. The DHT-suppressing effects of dutasteride and finasteride, the prostaglandin signaling of latanoprost, and the vasodilatory mechanism of minoxidil all require consistent daily use to maintain their effect. Missing a day here and there is less critical than being generally consistent over time. Set a nightly reminder if needed.
Pregnancy hard contraindication: Both dutasteride (FDA Pregnancy Category X) and finasteride are contraindicated in pregnancy. These drugs can cause serious abnormalities in male fetuses and are absorbed through skin. Keep this product away from pregnant women and women who may become pregnant. Wash hands immediately and thoroughly after every application.
Six mechanisms addressed simultaneously: dual-enzyme DHT suppression (dutasteride + finasteride), scalp vasodilation (minoxidil), prostaglandin-mediated follicle cycling (latanoprost), fungal/inflammatory environment control (ketoconazole), and minoxidil bioavailability enhancement (tretinoin)
Three-year data: dutasteride increased hair thickness in 83.3% of women with androgenetic alopecia
5-alpha reductase inhibitors are the preferred systemic therapy for FFA according to the SOFFIA 2024 international expert consensus (69 hair experts, six continents)
2024 case study from University of Miami: topical latanoprost 0.005% stabilized FFA progression in a patient with recalcitrant 8-year biopsy-proven FFA within 10 months
How HerTeleMeds Works
Answer a few questions about your skin and medical history.
A U.S.-licensed provider reviews your information within 24 hours.
If prescribed, your compounded formula is made fresh and arrives discreetly — often within 2–3 days.
One application a day. Results build gradually with consistent use.
Product details
FAQ
Because FPHL — particularly complex presentations that haven’t responded to sequential therapy — is driven by more than one mechanism. DHT-mediated miniaturization, reduced scalp circulation, prostaglandin signaling dysfunction, scalp inflammation, fungal dysbiosis, and impaired minoxidil activation can all contribute simultaneously. A single active addresses one of these. Flourish addresses all six — compounded at therapeutic concentrations and prescribed by a clinician who has assessed your specific presentation.
Dutasteride inhibits both Type 1 and Type 2 5-alpha reductase; finasteride targets primarily Type 2. Patent-published combination data on minoxidil, finasteride, and latanoprost shows improved properties in terms of reduction of hair loss and increase of regrowth compared to any component taken individually, with results that may exceed the sum of the components. Including both 5-alpha reductase inhibitors provides dual-layer DHT suppression through complementary mechanisms.
Latanoprost is a prostaglandin F2α analog — the same active ingredient in Latisse — that works through a completely different mechanism than DHT inhibition or vasodilation. It prolongs the anagen (growth) phase through prostaglandin receptor signaling at the follicle. A 2024 case study from the University of Miami demonstrated FFA stabilization with latanoprost monotherapy, and latanoprost has been shown to significantly increase hair density at 24 weeks in androgenetic alopecia. For patients with complex or refractory hair loss, adding a third distinct mechanism provides meaningful additional coverage.
This is a clinical question that requires an individual assessment. 5-alpha reductase inhibitors are the preferred systemic therapy for FFA according to the SOFFIA 2024 international expert consensus. Flourish contains both finasteride and dutasteride as topical 5-ARIs. FFA is the most common type of scarring alopecia and most commonly affects postmenopausal women — there is no cure and the goal of treatment is stabilization. Your HerTeleMeds clinician will assess whether this formulation is appropriate for your specific diagnosis and history.
Commercial compounded stacks from telehealth platforms typically contain four or five actives. Flourish’s six-active protocol adds both finasteride and dutasteride as complementary DHT-blocking layers alongside latanoprost, which most four-active formulas omit. Every HerTeleMeds prescription is assessed individually — the six-active formulation is prescribed for patients whose clinical profile specifically calls for all six mechanisms, not offered as a default upgrade.
Reduced shedding is typically the first observable change, within 4–8 weeks. Initial regrowth at thinning or receding areas typically becomes visible by months 3–4. Density improvement continues building through 6–12 months of consistent use. For FFA patients, the primary goal is stabilization — halted progression — which is itself a meaningful clinical outcome for this condition.
Stopping treatment typically results in renewed progression within 6–12 months as the protective mechanisms are withdrawn. This is a maintenance protocol as much as a treatment protocol. Your HerTeleMeds clinician will advise on long-term management and whether any actives can be stepped down over time.
Flourish Hair Growth Serum is for women whose hair loss hasn’t responded fully to single-agent approaches — and who are ready for a clinician-prescribed, six-mechanism protocol designed for the complexity of what they’re facing. A HerTeleMeds clinician will review your history, confirm this formulation is right for your profile, and get you started on a protocol built to work with every pathway involved.
Start your consultationShips in 2–3 days. Prescription included with your visit. Cancel anytime.
